Stay updated on Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Footer revision tag updated to 'Revision: v3.3.3'. The HHS Vulnerability Disclosure link was removed, along with the previous 'Revision: v3.3.2' entry.
    Difference
    0.1%
    Check dated 2025-12-23T14:26:51.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the page. No study details or eligibility criteria appear to be affected.
    Difference
    0.1%
    Check dated 2025-11-24T17:57:55.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Deletion of a government funding status notice from the page; no core study content such as eligibility criteria, outcomes, or locations was changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T17:50:13.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page content is unchanged aside from a refreshed last update timestamp in the Study Record Dates. No changes to eligibility, interventions, or outcomes are observed.
    Difference
    0.5%
    Check dated 2025-11-03T12:34:01.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    3%
    Check dated 2025-10-05T16:43:18.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.1%
    Check dated 2025-09-28T10:06:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page.